01:59 PM EDT, 04/08/2026 (MT Newswires) -- Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 1.9%.

The iShares Biotechnology ETF (IBB) climbed 2%.

In corporate news, AbbVie ( ABBV ) said Wednesday it has filed a lawsuit seeking to narrow and clarify the definition of an eligible patient under the federal 340B drug discount program. Its shares rose 2%.

Waters (WAT) shares climbed 4.5% after it said Wednesday that the US Food and Drug Administration cleared its Onclarity HPV Self-Collection Kit for at-home use and approved the BD Onclarity HPV Assay with extended genotyping.

Bausch + Lomb ( BLCO ) shares gained 3.9% after it said Wednesday the US Food and Drug Administration cleared its dual-port vitrectomy cutter and a fluidics software update for its vision enhancement system, used for retinal surgery.

GSK (GSK) shares gained 2.5% after it said China's National Medical Products Administration approved its biologic medication Exdensur as a supplemental therapy for adults suffering from chronic rhinosinusitis with nasal polyps.